Sara Eichau

Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study

Anna He, B. Merkel, J William L Brown et al. · The Lancet Neurology · 2020 · 401 citations · Full text

Disease Progression, Neurological Disorder, Clinical Epidemiology +7

Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis

Wei Zhen Yeh, Putu Ayu Widyastuti, Anneke van der Walt et al. · Neurology · 2021 · 76 citations · Full text

Early clinical markers of aggressive multiple sclerosis

Charles B. Malpas, Ali Manouchehrinia, Sifat Sharmin et al. · Brain · 2020 · 58 citations · Full text

Disease Progression, Neurological Disorder, Aggressive Multiple Sclerosis +18

Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity

Vilija Jokubaitis, Maria Pia Campagna, Omar Ibrahim et al. · Brain · 2022 · 45 citations

Neurogenomics, Genetics, Genetic Epidemiology +27

Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis

Izanne Roos, Charles B. Malpas, Emmanuelle Leray et al. · Neurology · 2022 · 44 citations · Full text